Concert Pharmaceuticals to Participate in Fireside Chat at The JMP Securities Life Sciences Conference

Rhea-AI Summary

Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) will participate in a fireside chat at the JMP Securities Life Sciences Conference on June 16, 2022, at 1:00 p.m. ET, in New York, NY. Investors can access a webcast of the chat on the Company’s website, with a replay available for two weeks post-event. Concert is a clinical stage biopharmaceutical company focusing on developing small molecule drugs, particularly its lead product candidate for alopecia areata, using its innovative DCE Platform for improved pharmacokinetics.

LEXINGTON, Mass.--(BUSINESS WIRE)-- Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it will participate in a fireside chat at The JMP Securities Life Sciences Conference on June 16, 2022 at 1:00 p.m. ET in New York, NY.

A webcast of the JMP fireside chat may be accessed in the Investors section of the Company’s website at www.concertpharma.com. A replay of the webcast will be available on Concert’s website for two weeks following the presentation.

About Concert

Concert Pharmaceuticals is a clinical stage biopharmaceutical company that is developing small molecule drugs that it discovered through the application of its DCE Platform^® (deuterated chemical entity platform). Selective incorporation of deuterium into known molecules has the potential, on a case-by-case basis, to provide better pharmacokinetic or metabolic properties, thereby enhancing their clinical safety, tolerability or efficacy. Concert’s lead product candidate is in late-stage development for the treatment of alopecia areata, a serious autoimmune dermatological condition. Concert is also assessing a number of earlier-stage pipeline candidates. For more information please visit www.concertpharma.com or follow us on Twitter at @ConcertPharma or on LinkedIn.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220609005071/en/

Justine Koenigsberg

(781) 674-5284

ir@concertpharma.com

Source: Concert Pharmaceuticals, Inc.

FAQ

When is Concert Pharmaceuticals participating in the JMP Securities Life Sciences Conference?

Concert Pharmaceuticals will participate in the JMP Securities Life Sciences Conference on June 16, 2022, at 1:00 p.m. ET.

How can investors access the webcast of the Concert Pharmaceuticals fireside chat?

Investors can access the webcast of the Concert Pharmaceuticals fireside chat through the Investors section of the Company's website.

What is the focus of Concert Pharmaceuticals' development efforts?

Concert Pharmaceuticals is focused on developing small molecule drugs, particularly targeting alopecia areata using its DCE Platform.

How long will the replay of the webcast be available for Concert Pharmaceuticals?

The replay of the webcast from the Concert Pharmaceuticals fireside chat will be available for two weeks following the presentation.

What is the ticker symbol for Concert Pharmaceuticals?

The ticker symbol for Concert Pharmaceuticals is CNCE.